Evaluation of the Cost Per Patient Achieving Composite and Single Treatment Targets with Once-Weekly Semaglutide and Exenatide ER in the United States
May 1, 2018, 00:00
10.1016/j.jval.2018.04.501
https://www.valueinhealthjournal.com/article/S1098-3015(18)30801-5/fulltext
Title :
Evaluation of the Cost Per Patient Achieving Composite and Single Treatment Targets with Once-Weekly Semaglutide and Exenatide ER in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30801-5&doi=10.1016/j.jval.2018.04.501
First page :
Section Title :
Open access? :
No
Section Order :
1304